In this article, the results of a bibliographic research concerning the interactions between bariatric surgery and psychopathologies are presented. In the preoperative phase, although not scientifically demonstrated, uncontrolled psychopathologies as well as the abuse of illicit substances are often considered as exclusion criteria for the intervention. From the psychological point of view, neither the existence of a "typical" profile, nor the presence of predictive factors have been demonstrated. However some "attitudes" or "personality traits" could influence the issue of the intervention. In the postoperative phase, the pre-existing psychopathologies transiently improve. On the other hand, alcohol and illicit substances abuse as well as suicide are increased.

Download full-text PDF

Source

Publication Analysis

Top Keywords

interactions bariatric
8
bariatric surgery
8
illicit substances
8
[reciprocal interactions
4
surgery psychopathology]
4
psychopathology] article
4
article bibliographic
4
bibliographic concerning
4
concerning interactions
4
surgery psychopathologies
4

Similar Publications

Obesity represents a global epidemic associated with significant health risks, including diabetes, cardiovascular disease, and certain cancers. Management strategies have evolved from focusing solely on weight reduction to emphasizing overall health improvements and mitigating associated risks. This narrative review analyzed the existing peer-reviewed literature across databases such as PubMed, Scopus, EMBASE, the Cochrane Library, and Google Scholar to examine the outcomes of bariatric surgery and its interplay with weight stigma.

View Article and Find Full Text PDF

The interplay between the gut microbiota and gastrointestinal hormones plays a pivotal role in the health of the host and the development of diseases. As a vital component of the intestinal microecosystem, the gut microbiota influences the synthesis and release of many gastrointestinal hormones through mechanisms such as modulating the intestinal environment, producing metabolites, impacting mucosal barriers, generating immune and inflammatory responses, and releasing neurotransmitters. Conversely, gastrointestinal hormones exert feedback regulation on the gut microbiota by modulating the intestinal environment, nutrient absorption and utilization, and the bacterial biological behavior and composition.

View Article and Find Full Text PDF

Obstructive sleep apnea in bariatric surgery patients: a population-based study.

Sleep Breath

January 2025

Department of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, ON, Canada.

Purpose: A high proportion of obstructive sleep apnea (OSA) remains undiagnosed. The main objectives of this study were to measure the prevalence of diagnosed OSA and determine OSA predictors in patients who underwent bariatric surgery, who are predominantly female and pre-menopausal and represent an understudied population in OSA literature.

Methods: This was a cross-sectional population-based study using the Ontario Bariatric Registry (OBR) from 2010 to 2016, linked to ICES databases which include health administrative data on all encounters within a single public-payer system.

View Article and Find Full Text PDF

Intestinal epithelial cell NCoR deficiency ameliorates obesity and metabolic syndrome.

Acta Pharm Sin B

December 2024

State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

Nuclear receptor corepressor (NCoR1) interacts with various nuclear receptors and regulates the anabolism and catabolism of lipids. An imbalance in lipid/energy homeostasis is also an important factor in obesity and metabolic syndrome development. In this study, we found that the deletion of NCoR1 in intestinal epithelial cells (IECs) mainly activated the nuclear receptor PPAR and attenuated metabolic syndrome by stimulating thermogenesis.

View Article and Find Full Text PDF

LEAP2 in Physiology-A Narrative Review.

Int J Mol Sci

January 2025

Department of Animal Physiology, Biochemistry and Biostructure, Poznan University of Life Sciences, Wolynska 35 Street, 60-637 Poznan, Poland.

Liver Enriched Antimicrobial Peptide 2 (LEAP2) is a fascinating peptide that has gained significant attention since its discovery in 2003. Initially identified as an antimicrobial peptide, LEAP2 has more recently been found to play a key role in the regulation of energy metabolism. One of the most notable functions of LEAP2 is its interaction with the ghrelin hormone, which is known for stimulating hunger.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!